Recaticimab in adult heterozygous familial hypercholesterolemia (REMAIN-3): A multicentre, randomised, double-blind, placebo-controlled phase 3 study
1. 系统已在2025-09-17 14:53:57对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1093/cvr/cvaf155
文献链接: https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvaf155/8248561
其他信息:
出版社: Oxford University Press (OUP)
作者: Liwen Li; Yujie Zhou; Chanjuan Deng; Jianlong Sheng; Daoquan Peng; Zhiyu Ling; Luya Wang; Cuilian Dai; Kai Huang; Qiufang Lian; Zaixin Yu; Haibo Yang; Yuying Hu; YuGang Dong; Nan Wang; Zhen Wang; Wei Zhang; Xuebin Han; Zhuhua Yao; Qiyun Liu; Yingzi Liang; Biao Xu; Ying Wang; Tingyan Zhong; Jiyan Chen
全文下载地址: https://academic.oup.com/cardiovascres/advance-article-pdf/doi/10.1093/cvr/cvaf155/64215658/cvaf155.pdf
